Oncternal Therapeutics, Inc. (ONCT)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 8.96 |
| Open | 8.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 8.74 - 8.74 |
| 52 Week Range | 5.57 - 13.20 |
| Volume | |
| Avg. Volume | 7,769 |
| Market Cap | 25.882M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Oncternal Therapeutics ( NASDAQ:ONCT ) Full Year 2023 Results Key Financial Results Net loss: US$39.5m (loss narrowed...
- Insider Monkey
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Oncternal Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15. Operator: Greetings and welcome to Oncternal Therapeutics third-quarter 2023 financial results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to […]
- Simply Wall St.
We're A Little Worried About Oncternal Therapeutics' (NASDAQ:ONCT) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
© 2024 Yahoo. All rights reserved.